If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
HEMATOLOGY
EMJ Hematol. 2017 Suppl 10 • europeanmedical-journal.com
INSIDE
Improving Treatment Strategies for
Patients with Follicular Lymphoma:
How to Translate Novel Study
Data into Clinical Practice
IMPROVING TREATMENT STRATEGIES FOR PATIENTS
WITH FOLLICULAR LYMPHOMA: HOW TO TRANSLATE
NOVEL STUDY DATA INTO CLINICAL PRACTICE
This satellite symposium took place on 13th June 2017
as a part of the 14th International Conference on
Malignant Lymphoma (ICML) in Lugano, Switzerland
Chairperson
Bruce Cheson1
Speakers
Rosmarie Pfau,2 Mathias Rummel,3 Andrew Davies,4 Gilles Salles5
1. Georgetown University Hospital,
Lombardi Comprehensive Cancer Center, Washington DC, USA
2. Board Member of the Lymphom
HEMATOLOGY EMJ Hematol. 2017 Suppl 10 • europeanm
IMPROVING TREATMENT STRATEGIES FOR PATIENTS WITH
Management Issues in
These issues strongly influence a patients’ QoL, e
time-to-event endpoints, such as event-free survi
1.0 0.8 PFS probability 0.6 0.4 0.2R-chem
PFS (3-year PFS: 81.9% versus 77.9%; HR 0.71; 95%
microtubule disruption.39 While the clinical effi
REFERENCES 1. Casulo C et al. Early relaps
2016;27(Suppl 5):v83-90. 33. National Compreh